Supplementary
Materials
Pulim, V., Bienkowska, J., Berger B., LTHREADER: PREDICTION OF LIGAND-RECEPTOR INTERACTIONS USING LOCALIZED THREADING. Pacific Symposium on Biocomputing 12:64-75 (2007).
Table S1: Datasets: Long-chain 4-helical bundle and TNF-like cytokine ligands and receptor
4-Helical Bundle Cytokines |
|
Abbreviation |
Name |
Ligands |
|
EPO |
Erythropoietin |
CSF3 |
Colony stimulating factor 3 |
GH |
Growth hormone |
IL6 |
Interleukin 6 |
LIF |
Leukemia inhibitory factor |
OSM |
Oncostatin M |
CNTF |
Ciliary neurotrophic factor |
IL23 |
Interleukin 23 |
IL12 |
Interleukin 12 |
LEP |
Leptin |
PRL |
Prolactin |
Receptors |
|
EPOR |
Erythropoietin receptor |
CSF3R |
Colony stimulating factor 3 receptor |
GHR |
Growth hormone receptor |
GP130 |
GP130 |
IL12R |
Interleukin 12 receptor |
LEPR |
Leptin receptor |
PRLR |
Prolactin receptor |
TNF-Like Cytokines |
|
Abbreviation |
Name |
Ligands |
|
TNFSF1 |
Lymphotoxin alpha (LTA) |
TNFSF2 |
Tumor necrosis factor (TNF) |
TNFSF3 |
Lymphotoxin beta (LTB) |
TNFSF4 |
OX40 antigen ligand (OX40L) |
TNFSF5 |
CD40 antigen ligand (CD40L) |
TNFSF6 |
Fas antigen ligand (FASL) |
TNFSF10 |
TNF-related apoptosis inducing ligand (TRAIL) |
TNFSF11 |
Receptor activator of NF-kappa-B ligand (RANKL) |
TNFSF12 |
TNF-related weak inducer of apoptosis (TWEAK) |
TNFSF13 |
APOL-related leukocyte expressed ligand 2 (APRIL) |
TNFSF13B |
B-cell activating factor (BAFF) |
TNFSF15 |
TNF ligand-related molecule 1 (TL1A) |
Receptors |
|
TNFRSF1A |
Tumor necrosis factor receptor 1 (TNFR1) |
TNFRSF1B |
Tumor necrosis factor receptor 2 (TNFR2) |
TNFRSF4 |
OX40 antigen (OX40) |
TNFRSF5 |
CD40 antigen (CD40) |
TNFRSF6 |
Fas antigen (FAS) |
TNFRSF6B |
Decoy receptor 3 (DcR3) |
TNFRSF10B |
TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2) |
TNFRSF11A |
Receptor activator of NF-kappaB (RANK) |
TNFRSF11B |
Osteoprotegerin (OPG) |
TNFRSF12 |
DR3 |
TNFRSF12A |
Type I transmembrane protein Fn14 |
TNFRSF13B |
Transmembrane activator and CAML interactor (TACI) |
TNFRSF13C |
B-cell activating factor receptor (BAFFR) |
TNFRSF17 |
B-cell maturation factor (BCMA) |
LTBR |
Lymphotoxin B receptor |
Table S2: Datasets: Template complexes
4-Helical Bundle Cytokine
Complexes |
||
Ligand |
Receptor |
PDB ID |
CSF3 |
CSF3R |
1cd9 |
EPO |
EPOR |
1cn4 |
GH |
GHR |
1hwg |
IL6 |
GP130 |
1p9m |
LIF |
GP130 |
1pvh |
TNF-Like Cytokine Complexes |
||
Ligand |
Receptor |
PDB ID |
TNFSF10 |
TNFRSF10B |
1dog |
TNFSF13 |
TNFRSF13B |
1xu1 |
TNFSF13 |
TNFRSF17 |
1xu2 |
TNFSF13B |
TNFRSF13C |
1oqe |
TNFSF13B |
TNFRSF17 |
1oqd |
Table S3: Comparison of single and combined scoring methods using 1-fold cross validation on experimentally confirmed binding and non-binding pairs of ligands and receptors. “YES” indicates the method predicted the pair binds, “NO” that the pair does not bind. Green shading indicates that the prediction agrees with experimental data; red that it does not. See Section 3.3 for definitions of the CM, SP, FF and CR scoring methods. The significance of predicting interactions is equals to 1 minus the frequency of predicting interactions between pairs using randomized interaction surfaces.
4-Helical Bundle Cytokines |
|||||||
Ligand |
Receptor |
Binding? |
|||||
Binding Pairs |
Exp |
CM |
SP |
FF |
CR |
All |
|
EPO |
EPOR |
YES |
NO |
YES |
YES |
NO |
YES |
CSF3 |
CSF3R |
YES |
NO |
YES |
NO |
YES |
NO |
GH |
GHR |
YES |
YES |
YES |
NO |
YES |
YES |
IL6 |
GP130 |
YES |
YES |
NO |
NO |
YES |
YES |
LIF |
GP130 |
YES |
NO |
NO |
YES |
YES |
YES |
OSM |
GP130 |
YES |
YES |
YES |
NO |
NO |
YES |
CNTF |
GP130 |
YES |
YES |
YES |
YES |
YES |
YES |
CTF1 |
GP130 |
YES |
YES |
YES |
NO |
NO |
YES |
IL23 |
IL12R |
YES |
YES |
YES |
NO |
YES |
YES |
IL12 |
IL12R |
YES |
YES |
NO |
NO |
YES |
YES |
LEP |
LEPR |
YES |
NO |
NO |
YES |
NO |
NO |
PRL |
PRLR |
YES |
NO |
YES |
NO |
NO |
NO |
Non-Binding Pairs |
|
||||||
IL6 |
EPOR |
NO |
NO |
NO |
NO |
NO |
NO |
IL6 |
CSF3R |
NO |
YES |
YES |
NO |
NO |
YES |
CSF3 |
EPOR |
NO |
NO |
NO |
NO |
NO |
NO |
LEP |
GHR |
NO |
NO |
NO |
NO |
YES |
NO |
OSM |
CSF3R |
NO |
NO |
YES |
NO |
YES |
NO |
LEP |
GP130 |
NO |
NO |
NO |
NO |
YES |
NO |
GH |
GP130 |
NO |
NO |
YES |
NO |
YES |
NO |
EPO |
GP130 |
NO |
NO |
YES |
NO |
NO |
NO |
IL12 |
GP130 |
NO |
NO |
YES |
NO |
NO |
NO |
IL23 |
GP130 |
NO |
NO |
YES |
NO |
NO |
NO |
IL12 |
EPOR |
NO |
NO |
NO |
NO |
NO |
NO |
IL23 |
EPOR |
NO |
NO |
NO |
NO |
NO |
NO |
IL6 |
PRLR |
NO |
NO |
YES |
NO |
NO |
YES |
IL12 |
LEPR |
NO |
NO |
NO |
NO |
YES |
NO |
Sensitivity |
58% |
67% |
33% |
50% |
75% |
||
Specificity |
93% |
50% |
100% |
64% |
86% |
||
Significance |
|
|
|
|
0.62 |
TNF-Like Cytokines |
|||||||
Ligand |
Receptor |
Binding? |
|||||
Binding Pairs |
Exp |
CM |
SP |
FF |
CR |
All |
|
SF1 |
RSF1A |
YES |
NO |
NO |
NO |
YES |
YES |
SF1 |
RSF1B |
YES |
NO |
NO |
NO |
NO |
YES |
SF1 |
RSF14 |
YES |
NO |
NO |
NO |
YES |
YES |
SF2 |
RSF1A |
YES |
NO |
NO |
NO |
YES |
YES |
SF2 |
RSF1B |
YES |
NO |
NO |
YES |
NO |
YES |
SF3 |
RSF1A |
YES |
NO |
YES |
NO |
NO |
NO |
SF3 |
RSF1B |
YES |
YES |
YES |
NO |
YES |
YES |
SF3 |
LTBR |
YES |
YES |
NO |
NO |
NO |
YES |
SF4 |
RSF4 |
YES |
NO |
NO |
NO |
YES |
YES |
SF5 |
RSF5 |
YES |
NO |
YES |
NO |
NO |
NO |
SF6 |
RSF6 |
YES |
NO |
NO |
YES |
YES |
YES |
SF6 |
RSF6B |
YES |
NO |
NO |
YES |
YES |
YES |
SF10 |
RSF11B |
YES |
NO |
NO |
NO |
NO |
YES |
SF11 |
RSF11A |
YES |
NO |
YES |
NO |
NO |
NO |
SF11 |
RSF11B |
YES |
NO |
YES |
NO |
NO |
YES |
SF12 |
RSF12A |
YES |
NO |
NO |
YES |
YES |
YES |
SF13 |
RSF17 |
YES |
NO |
NO |
NO |
YES |
NO |
SF13B |
RSF17 |
YES |
NO |
NO |
NO |
YES |
NO |
SF15 |
RSF6B |
YES |
NO |
NO |
YES |
NO |
NO |
SF15 |
RSF12 |
YES |
NO |
YES |
YES |
YES |
YES |
Non-Binding Pairs |
|
||||||
SF1 |
LTBR |
NO |
YES |
YES |
NO |
NO |
NO |
SF1 |
RSF4 |
NO |
YES |
NO |
NO |
YES |
YES |
SF1 |
RSF5 |
NO |
YES |
YES |
NO |
NO |
YES |
SF2 |
RSF6 |
NO |
NO |
NO |
NO |
YES |
NO |
SF2 |
RSF6B |
NO |
YES |
YES |
NO |
YES |
YES |
SF3 |
RSF11A |
NO |
YES |
YES |
NO |
NO |
NO |
SF3 |
RSF11B |
NO |
NO |
YES |
NO |
YES |
NO |
SF3 |
RSF12A |
NO |
NO |
NO |
NO |
YES |
NO |
SF4 |
RSF17 |
NO |
YES |
NO |
NO |
YES |
YES |
SF5 |
RSF6B |
NO |
YES |
NO |
NO |
NO |
NO |
SF6 |
RSF12 |
NO |
NO |
YES |
NO |
YES |
YES |
SF6 |
LTBR |
NO |
YES |
YES |
YES |
NO |
NO |
SF10 |
RSF4 |
NO |
YES |
YES |
NO |
YES |
NO |
SF11 |
RSF5 |
NO |
YES |
YES |
NO |
NO |
NO |
SF11 |
RSF6 |
NO |
YES |
YES |
YES |
YES |
YES |
SF12 |
RSF6B |
NO |
NO |
YES |
YES |
YES |
YES |
SF13 |
RSF11A |
NO |
NO |
YES |
YES |
YES |
NO |
SF13B |
RSF11B |
NO |
YES |
YES |
NO |
YES |
NO |
SF15 |
RSF12A |
NO |
YES |
NO |
YES |
YES |
YES |
SF15 |
RSF17 |
NO |
NO |
NO |
YES |
YES |
YES |
Sensitivity |
|
10% |
30% |
30% |
55% |
70% |
|
Specificity |
|
35% |
35% |
70% |
30% |
55% |
|
Significance |
|
|
|
|
|
0.81 |
Table S4: Comparison of sensitivity and specificity values for raw versus normalized scores for both the standalone CM and combined methods.
|
Raw |
Normalized |
CM Sensitivity |
33% |
58% |
CM Specificity |
57% |
93% |
Combined Sensitivity |
33% |
75% |
Combined Specificity |
50% |
86% |
Table S5:
Query Ligand-Receptor Pair |
Template Complex |
% similarity of
query ligand to template ligand |
% of interacting
residue pairs correctly identified (RAPTOR) |
% of interacting
residues correctly identified (LTHREADER) |
GH-GHR |
IL6-GP130 |
23 |
33 |
53 |
GH-GHR |
EPO-EPOR |
15 |
30 |
55 |
GH-GHR |
CSF3-CSF3R |
20 |
31 |
63 |
EPO-EPOR |
IL6-GP130 |
24 |
29 |
51 |
EPO-EPOR |
GH-GHR |
25 |
44 |
43 |
EPO-EPOR |
CSF3-CSF3R |
18 |
31 |
58 |
IL6-GP130 |
GH-GHR |
22 |
28 |
52 |
IL6-GP130 |
EPO-EPOR |
17 |
40 |
63 |
IL6-GP130 |
CSF3-CSF3R |
21 |
42 |
66 |
CSF3-CSF3R |
IL6-GP130 |
24 |
51 |
57 |
CSF3-CSF3R |
EPO-EPOR |
19 |
33 |
61 |
CSF3-CSF3R |
GH-GHR |
25 |
32 |
52 |
Average |
21 |
35 |
56 |
Table S6:
Query Ligand-Receptor Pair |
Template Complex |
% similarity of
query receptor to template receptor |
% of interacting
residue pairs correctly identified (RAPTOR) |
% of interacting
residues correctly identified (LTHREADER) |
TNFSF13B-TNFRSF17 |
TNFSF13-TNFRSF13B |
23 |
41 |
68 |
TNFSF13B-TNFRSF17 |
TNFSF10-TNFRSF10B |
16 |
30 |
55 |
TNFSF13B-TNFRSF17 |
TNFSF13B-TNFRSF13C |
39 |
60 |
82 |
TNFSF13B-TNFRSF13C |
TNFSF13-TNFRSF13B |
29 |
35 |
65 |
TNFSF13B-TNFRSF13C |
TNFSF10-TNFRSF10B |
18 |
25 |
45 |
TNFSF13B-TNFRSF13C |
TNFSF13B-TNFRSF17 |
39 |
54 |
66 |
TNFSF10-TNFRSF10B |
TNFSF13-TNFRSF13B |
29 |
56 |
54 |
TNFSF10-TNFRSF10B |
TNFSF13B-TNFRSF17 |
16 |
32 |
58 |
TNFSF10-TNFRSF10B |
TNFSF13B-TNFRSF13C |
18 |
42 |
38 |
TNFSF13-TNFRSF13B |
TNFSF13B-TNFRSF17 |
23 |
56 |
74 |
TNFSF13-TNFRSF13B |
TNFSF10-TNFRSF10B |
29 |
40 |
62 |
TNFSF13-TNFRSF13B |
TNFSF13B-TNFRSF13C |
29 |
45 |
84 |
Average |
25 |
43 |
63 |